These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 32311115

  • 1. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
    Mole AJ, Bell S, Thomson AK, Dissanayake KN, Ribchester RR, Murray LM.
    J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115
    [Abstract] [Full Text] [Related]

  • 2. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
    Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH.
    Hum Mol Genet; 2008 Apr 01; 17(7):949-62. PubMed ID: 18065780
    [Abstract] [Full Text] [Related]

  • 3. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, Thabet M, Paul B, Reilly A, Gagnon S, Renaud JM, Kothary R.
    EBioMedicine; 2020 May 01; 55():102750. PubMed ID: 32339936
    [Abstract] [Full Text] [Related]

  • 4. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R.
    Neuromuscul Disord; 2012 Mar 01; 22(3):263-76. PubMed ID: 22071333
    [Abstract] [Full Text] [Related]

  • 5. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL, Chen TH, Hsu YY, Cheng YH, Juang BT, Jong YJ.
    PLoS One; 2016 Mar 01; 11(4):e0154723. PubMed ID: 27124114
    [Abstract] [Full Text] [Related]

  • 6. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR.
    J Neurosci; 2010 Sep 08; 30(36):12005-19. PubMed ID: 20826664
    [Abstract] [Full Text] [Related]

  • 7. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, Xu X, Davis C, Wooley J, Goldhamer DJ, Lutz CM, Rich MM, Sumner CJ.
    J Neurosci; 2012 Jun 20; 32(25):8703-15. PubMed ID: 22723710
    [Abstract] [Full Text] [Related]

  • 8. Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy.
    Quinlan KA, Reedich EJ, Arnold WD, Puritz AC, Cavarsan CF, Heckman CJ, DiDonato CJ.
    J Neurophysiol; 2019 Oct 01; 122(4):1297-1311. PubMed ID: 31365319
    [Abstract] [Full Text] [Related]

  • 9. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Bhanot K, Kothary R.
    Neurobiol Dis; 2013 Jan 01; 49():57-67. PubMed ID: 22960106
    [Abstract] [Full Text] [Related]

  • 10. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.
    Miller N, Feng Z, Edens BM, Yang B, Shi H, Sze CC, Hong BT, Su SC, Cantu JA, Topczewski J, Crawford TO, Ko CP, Sumner CJ, Ma L, Ma YC.
    J Neurosci; 2015 Apr 15; 35(15):6038-50. PubMed ID: 25878277
    [Abstract] [Full Text] [Related]

  • 11. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH, Nijssen J, Frost-Nylen J, Hedlund E.
    J Comp Neurol; 2016 May 01; 524(7):1424-42. PubMed ID: 26502195
    [Abstract] [Full Text] [Related]

  • 12. Rapid loss of motor nerve terminals following hypoxia-reperfusion injury occurs via mechanisms distinct from classic Wallerian degeneration.
    Baxter B, Gillingwater TH, Parson SH.
    J Anat; 2008 Jun 01; 212(6):827-35. PubMed ID: 18510509
    [Abstract] [Full Text] [Related]

  • 13. Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy.
    Courtney NL, Mole AJ, Thomson AK, Murray LM.
    Cell Death Dis; 2019 Jul 04; 10(7):515. PubMed ID: 31273192
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Gibeault S, Courtney NL, Kothary R.
    Acta Neuropathol Commun; 2015 Sep 15; 3():55. PubMed ID: 26374403
    [Abstract] [Full Text] [Related]

  • 15. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.
    Udina E, Putman CT, Harris LR, Tyreman N, Cook VE, Gordon T.
    J Physiol; 2017 Mar 01; 595(5):1815-1829. PubMed ID: 27891608
    [Abstract] [Full Text] [Related]

  • 16. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy.
    Ling KK, Gibbs RM, Feng Z, Ko CP.
    Hum Mol Genet; 2012 Jan 01; 21(1):185-95. PubMed ID: 21968514
    [Abstract] [Full Text] [Related]

  • 17. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 18. Nerve sprouting capacity in a pharmacologically induced mouse model of spinal muscular atrophy.
    Rimer M, Seaberg BL, Yen PF, Lam S, Hastings RL, Lee YI, Thompson WJ, Feng Z, Metzger F, Paushkin S, Ko CP.
    Sci Rep; 2019 May 24; 9(1):7799. PubMed ID: 31127156
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of exercise-induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy-like mice.
    Ng SY, Mikhail A, Ljubicic V.
    J Physiol; 2019 Sep 24; 597(18):4757-4778. PubMed ID: 31361024
    [Abstract] [Full Text] [Related]

  • 20. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy.
    Kariya S, Mauricio R, Dai Y, Monani UR.
    Neurosci Lett; 2009 Jan 16; 449(3):246-51. PubMed ID: 19010394
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.